期刊文献+

激素受体阳性转移性乳腺癌的内分泌治疗 被引量:7

原文传递
导出
摘要 乳腺癌是女性常见的恶性肿瘤,以欧美国家发病率最高。随着我国人民群众生活水平的逐步提高,环境、饮食结构等因素的变化,我国乳腺癌的发病率呈逐年上升趋势。据国家癌症中心和国家卫生和计划生育委员会疾病预防控制局2013年中国肿瘤登记年报报道,全国肿瘤登记地区城市乳腺癌发病率2010年为47.79/10万,农村为27.72/10万。
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2015年第12期881-884,共4页 Chinese Journal of Oncology
关键词 乳腺肿瘤 肿瘤转移 药物疗法 激素受体阳性 内分泌治疗 氟维司群 Breast neoplasms Neoplasm metastatis Drug therepy Hormone receptor positive Endocrine therapy Fulvestrant
  • 相关文献

参考文献25

  • 1陈万青,张思维,曾红梅,郑荣寿,邹小农,赵平,吴良有,李光琳,赫捷.中国2010年恶性肿瘤发病与死亡[J].中国肿瘤,2014,23(1):1-10. 被引量:882
  • 2李婷,胡夕春.乳腺癌患者内分泌治疗的安全性管理[J].中华医学杂志,2012,92(20):1376-1378. 被引量:5
  • 3EllisMJ, Llombart-CussacA, FeltlD, et al. Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: overall survival analysis from the phase Ⅱ first study[J]. J Clin Oncol, 2015, 61:5831.
  • 4PriestmanT, BaumM, JonesV, et al. Treatment and survival on advanced breast cancer[J]. Br Med J, 1978, 2(6153):1673–1674.
  • 5TaylorSG 4th, GelmanRS, FalksonG, et al. Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women[J]. Ann Intern Med, 1986, 104(4):455–461.
  • 6A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. The Australian and New Zealand Breast Cancer Trials Group, Clinical Oncological Society of Australia[J]. J Clin Oncol, 1986, 4(2):186–193.
  • 7GuptaS, ZhangJ, JerusalemG. The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2-negative metastatic breast cancer: experience from the patient perspective[J]. Expert Rev Pharmacoeconomics Outcomes Res, 2014, 14(6):929–940.
  • 8KutomiG, OhmuraT, SatomiF, et al. A phase Ⅰ study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer[J]. Int J Clin Oncol, 2015, 20(3):474–479.
  • 9DranitsarisG, YuB, WangL, et al. Abraxane? versus Taxol? for patients with advanced breast cancer: a prospective time and motion analysis from a Chinese health care perspective[J]. J Oncol Pharm Pract, 2014, pii:1078155214556008.
  • 10WangT, YangTT, YangLJ, et al. Abstract P6-10-05: First-line chemotherapy versus first-line endocrine therapy in hormone receptor positive HER2 negative patients with metastatic breast cancer in China: Results of the study of breast cancer group of the Chinese Society of Clinical Oncology (CSCO)[J]. Cancer Res, 2013, 73(24Suppl): P6–10–05.

二级参考文献79

  • 1中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2011版)[J].中国癌症杂志,2011,21(5):367-417. 被引量:268
  • 2王中华,徐兵河.129例30岁以下女性乳腺癌的临床特点及预后分析[J].中华肿瘤杂志,2005,27(2):111-113. 被引量:40
  • 3宋三泰.乳癌内分泌治疗应该注意的几个问题[J].中国实用外科杂志,1997,17(2):70-72. 被引量:6
  • 4Coates AS, Keshaviah A, Thurlimann B, et al. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol, 2007,25 : 486- 492.
  • 5Forbes JF, Cuzick J, Buzdar A, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100- month analysis of the ATAC trial. Lancet Oncol,2008, 9:45-53.
  • 6Kaufmann M, Jonat W, Hilfrich J, et al. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 study. J Clin Oncol, 2007, 25 : 2664- 2670.
  • 7Coombes RC, Kilburn LS, Snowdon CF, et al. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment ( Intergroup Exemestane Study ) : a randomised controlled trial. Lancet ,2007,369:559-570.
  • 8Howell A, Cuzick J, Baum M, et al. Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination ) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet, 2005,365:60 -62.
  • 9Breast International Group (BIG) 1-98 Collaborative Group, Thurlimann B, Keshaviah A, Coates AS, et al. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med,2005 ,353 :2747-2757.
  • 10顾史洋,郭海宜,胡夕春,等.肿瘤内科药物不良反应的处理.见:胡夕春,主编.肿瘤内科方案的药物不良反应及对策.第一版.北京:人民卫生出版社,2009:454-455.

共引文献1492

同被引文献46

  • 1李金锋,徐光炜.乳腺癌的早期诊断与治疗[J].中华全科医师杂志,2005,4(6):336-338. 被引量:29
  • 2江泽飞,宋三泰,李家益,徐建明,刘晓晴,汤仲明.大剂量甲孕酮治疗复发转移乳癌[J].中华肿瘤杂志,1995,17(1):71-73. 被引量:12
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:278
  • 4罗葆明,欧冰,冯霞,文艳玲,智慧.乳腺肿块的超声弹性成像、多普勒超声及X线钼靶检查[J].中国医学影像技术,2006,22(12):1823-1826. 被引量:42
  • 5顾雅佳,汪晓红,肖勤,杨文涛,曾炜,唐峰,毛健,郑晓静,彭卫军,冯晓源.乳腺导管原位癌及其微浸润的磁共振成像评价[J].中华放射学杂志,2007,41(3):248-253. 被引量:43
  • 6Cardoso F, Loibl S, Pagani O, et al. The European Society ofBreast Cancer Specialists recommendations for the management of young women with breast cancer [J]. Eur J Cancer, 2012,48 ( 18 ) :3355 - 3377.
  • 7Jemal A, Bray F, Center MM, et al. Global cancer statistics [J].Cancer J clin, 2011,61 ( 2 ) :69 - 90.
  • 8Djilasivanovic D, Boban J, Katanic D, et al. Bilateral bloody nipple discharge in a male infant, sonographic findings and pro- posed diagnosis approach [ J ]. J Pediatr Endocrinol Metab, 2012,25( 1 -2) :163 - 164.
  • 9Ferrell N, Gallego - Perez D, Higuita - Castro N, et al. Vacuum - assisted cell seeding in a micro well cell culture system [ J]. A- nal Cbem, 2010,82(6) :2380 -2386.
  • 10Waldherr C, Cemy P, Ahematt HJ, et al. Value of one - view breast tomosynthes is versus two - view mammography in diagnos- tic workup of women with clinical signs and symptoms and in women recalled from screening [ J]. AJR, 2013,200( 1 ) :226 - 231.

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部